MetaVision SafeTrack chosen by University Hospital Southampton for electronic observations

iMDsoft announced that University Hospital Southampton NHS Foundation Trust (UHS) in the UK chose MetaVision SafeTrack™, iMDsoft's new mobile electronic observation solution, for all 1237 of its general ward level 1 beds. This agreement follows the hospital's choice of the MetaVision® Patient Data Management System (PDMS) for all of their high acuity environments.

UHS provides specialist services such as neurosciences, cardiac services and children's intensive care to more than 3 million people in central southern England and the Channel Islands. It is a major center for teaching and research in association with the University of Southampton.

The Trust acquired MetaVision SafeTrack with the aim of further improving patient safety in the hospital and reducing mortality numbers, following the procurement and implementation of an Electronic Patient Acuity Monitoring System (ePAMS). The acquisition was made after receiving funding from the Nursing Technology Fund earlier this year.

Using mobile devices across 57 wards, 3,000 nurses and midwives will replace paper with MetaVision SafeTrack to capture observations. Automated Modified Early Warning Score (MEWS) calculations and escalations will alert clinical teams to the need for intervention. The system will support the specific MEWS of the various hospital departments and can be adjusted for individual scores per patient. Smart alerts and nursing assessments for conditions such as sepsis, AKI and VTE will help identify possible patient deterioration.

The Trust also chose the MetaVision PDMS for their high acuity environments, and is now implementing the solution for over 100 anesthesia and intensive care beds. It is already live in the Surgical High Dependency unit and the Cardiac ICU, with the OR, GICU, Neuro ICU, PICU and NICU to follow shortly.

The MetaVision PDMS, installed in over 20 NHS hospitals, has a proven track record of delivering high impact results in complex clinical environments. MetaVision includes advanced tools for clinical assessment, treatment and care planning, providing complete electronic patient records. Powerful decision support options promote the uniform adoption of best practices. Automatic reporting for ICNARC & Critical Care Minimum Data Set eliminates the time and errors associated with manual data entry.

Adrian Byrne, Director of Information Management and Technology at University Hospital Southampton NHS Foundation Trust, said:

MetaVision SafeTrack will track the early warning score, giving us much better visibility of patient deterioration than in the past, and enabling a quicker and more appropriate response. Having vital sign data on the same platform as the critical care data is compelling for us, and will facilitate simple transition of patients across different levels of acuity."

"We are proud to further expand our relationship with Southampton and bring our newly released mobile observation solution to this leading organization," said Lars-Oluf Nielsen, CEO of iMDsoft. "MetaVision SafeTrack is backed by a decade of experience in collecting data at the point of care, digitizing clinical processes, and improving care for the sickest patients. We believe that the hospital will reap the benefits of timely intervention for critical cases throughout the hospital."

MetaVision SafeTrack will be presented at ANZICS in Auckland, New Zealand, 29-31 October; at EHI Live 2015 in Birmingham, the UK, 3-4 November; and at HISI in Dublin, Ireland, 25-26 November.

Source: iMDsoft

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover key mechanisms of CRISPR gene editing